Lavender Sandalwood Aromatherapy Study

Part of paid clinical trials in Houston, Texas.

Sponsor
Memorial Hermann Health System
Study ID
NCT07737392
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Mood
  • Pain
  • Patient Satisfaction
  • Scheduled Cesarean Sections

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lavender-sandalwood aromatherapy tabs — OTHER
    The intervention used in this study consists of aromatherapy tabs infused with lavender and sandalwood essential oils. These aromatabs are administered to participants following their cesarean section procedures to evaluate their effectiveness in managing postoperative pain. The choice of lavender and sandalwood is based on their widely recognized calming and analgesic properties, with the goal of providing non-pharmacological support for pain relief. Participants in the experimental group will receive these aromatabs according to the study protocol, allowing for a clear comparison of outcomes between the aromatherapy intervention and the control group.

Study Details

The purpose of this randomized controlled study is to explore whether lavender sandalwood aromatherapy can support comfort, mood, pain relief, and overall satisfaction for participants recovering from a scheduled cesarean section without complications. The main questions this study aims to answer are: * How does lavender sandalwood aromatherapy affect participants' mood during postpartum recovery after a cesarean section? * Does lavender sandalwood aromatherapy help reduce pain during recovery? * Does lavender sandalwood aromatherapy improve participants' overall satisfaction with their recovery experience? Researchers will compare participants who receive lavender-sandalwood aromatherapy with those who do not to determine whether it improves mood, reduces pain, and enhances patient satisfaction. Participants will be asked to: * Wear aromatherapy tabs on their gown for 24 hours. * Have the aromatherapy tabs applied 24 hours after the cesarean section and removed 48 hours after the cesarean section. * Complete surveys at 24 hours and 48 hours after the cesarean section. This will apply to both the control and intervention groups.

Key Dates

First listed
Jul 30, 2026
Start date
Sep 30, 2026
Status verified
Jul 2026
Primary completion
Aug 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
182 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Control group
    Participants assigned to the control group will receive standard post-operative care following their scheduled cesarean section, with no aromatherapy intervention. This approach enables a clear comparison with the experimental group to evaluate the impact of aromatherapy. The PANAS and DVPRS assessments will be administered at 24 and 48 hours post-surgery.
  • Experimental: Experimental group
    Participants assigned to the intervention group will have self-adhesive aromatherapy tabs applied to their hospital gowns within 24 hours after their cesarean surgery. These aromatabs, containing a blend of lavender and sandalwood essential oils, are worn continuously for 24 hours, delivering consistent aromatic exposure. After this 24-hour interval, the tabs will be removed 48 hours post-surgery. To assess the impact of the aromatherapy intervention, the Positive and Negative Affect Schedule (PANAS) and the Defense Veterans Pain Rating Scale (DVPRS) will be administered at both the 24-hour and 48-hour following surgery. This approach will allow for a detailed evaluation of changes in mood and pain levels associated with the use of Aromatabs during the immediate postoperative recovery period.

Primary Outcome Measure

PANAS survey to measure mood [ Time Frame: The period begins when you enroll and ends when you are discharged, and usually covers a timeframe of three to six days. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Memorial Hermann Memorial City Medical CenterHoustonTexas77024-

Find similar trials in Houston, TX

By research site
Memorial Hermann Memorial City Medical Center· Houston, TX

Related Studies